AARD logo
AARD NASDAQ US

Aardvark Therapeutics, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Feb 2025
$4.30
▲ +$0.21 (+5.13%)
Vol 133K
3
Quality Score
fail
Mkt Cap
$285.8M
ROE
-40.5%
D/E
0.00
Beta
1.34
52W
$5–$20

Wall Street Consensus

18 analysts · Apr 2026
7
Strong Buy
6
Buy
5
Hold
0
Sell
0
Strong Sell
72.2%
Buy Rating

Price Chart

Similar Stocks

ANTX
AN2 Therapeutics Inc
$31.2M
LONA
LeonaBio Inc
TTRX
Turn Therapeutics Inc
VRCA
Verrica Pharmaceuticals Inc
$78.9M
RANI
Rani Therapeutics Holdings Inc
$164.1M
PLRX
Pliant Therapeutics Inc
$75.0M
GRCE
Grace Therapeutics, Inc
$53.5M
CGTX
Cognition Therapeutics Inc
$119.2M

Earnings

Beat rate: 50.0%
Next Report May 12, 2026
EPS Estimate: $-0.90
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.90 — —
Dec 2025 $-0.85 $-0.81 +$0.04
Sep 2025 $-0.81 $-0.75 +$0.06
Jun 2025 $-0.61 $-0.66 $-0.05

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -33.3% -30.8% -33.3% -33.3% -33.3% -40.5%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 14.04 25.86 14.04 14.04 14.04 12.03

Key Ratios

ROA (TTM)
-37.9%
EPS (TTM)
$-2.53
52W High
$19.58
52W Low
$4.88
$4.88 52-Week Range $19.58

How does AARD compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

AARD ACB ACRS ADIL ADXN

AARD valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
—
▼ 0% below peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (2.0%)
vs Peers
vs Industry
Low yield

AARD profitability vs Pharmaceuticals peers

ROE
-40.5%
▲ 25% above peers (-54.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼ 0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
-37.9%
▼ 1% below peers (-37.4%)
vs Peers
vs Industry
In line

AARD financial health vs Pharmaceuticals peers

D/E ratio
0.0
▼ 100% below peers (1.5)
vs Peers
vs Industry
Low debt
Current ratio
12.0
▲ 258% above peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
▲ 43% above peers (0.9)
vs Peers
vs Industry
More volatile

AARD fundamentals radar

AARD Peer median Industry

AARD profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

AARD vs peers: key metrics

Latest News

No related news yet